CSE-1034 versus ceftriaxone: Efficacy and safety analysis from a randomized, open-labeled phase III study in complicated urinary tract infections

by Manu Chaudhary, Shiekh Gazalla Ayub, Mohd Amin Mir, Members of Study GroupFNx01
Published 2018-01-01